International Standards You Can Trust
a division of Pharmascience Inc.
Operating since 1994 and obtaining the lowest reanalysis rates in the industry of <2%, we have over 250 FDA/EMA compliant bioanalytical methods, including methods available for drugs currently on patent hold in Europe.
We have a state of the art cannabis testing facility, and are licensed by Health Canada since April 2018. Our lab is equipped to provide comprehensive testing using the latest Shimadzu LC/MS/MS, GC/MS/MS, ICP/MS equipment. We provide pesticide, potency, terpenes, mycotoxins, residual solvents, heavy metals, microbiology and stability testing for cannabis products.
News & Events
March 15 2021
Pharmascience Receives Standard Processing Licence from Health Canada
Pharmascience Inc. one of Canada’s largest pharmaceutical manufacturers, is pleased to announce the issuance by Health Canada of a Cannabis…
October 2 2019
Pharmascience, proud participant in Montreal Cannabis Expo
Royalmount Laboratories, a division of Pharmascience Inc. is proud to be participating for the first time in the Montreal Cannabis…
May 25 2018
Successful FDA Inspection
September 24 2018
Health Canada Audit
As part of the Health Canada Clinical Trial Compliance Inspection pilot program, the bioanalytical laboratory of Pharmascience was audited for…
Working with Royalmount Laboratories on Several Projects
We have had the pleasure of working with Royalmount Laboratories on several projects over the past few years. From developing challenging bioanalytical methods to supporting nonclinical programs, we have been continually impressed by the Royalmount Laboratories team’s work. They are communicative and consistently take the time to think and improve the project. They go above and beyond expectations to identify issues and discuss options that can improve programs. Royalmount Laboratories performs great science combined with experience and timely communications. We highly recommend their work and their team of scientists.
Bioanalytical Support for Drug Discovery Programs
In support of our drug discovery programs of small molecules, I had the pleasure to closely collaborate with the bioanalytical group. All along the team was committed and provided rapid turnaround of study protocols and reports. They were attentive to details, knowledgeable and gave pertinent feedback. The results were of high quality. Overall the collaboration was very positive and helped us to better allocate our internal resources and achieve our objectives in a timely and cost effective manner.